Students
Tuition Fee
SAR 200,000
Per course
Start Date
Not Available
Medium of studying
On campus
Duration
2 years

You've viewed 1/5 programs/universities. You can view up to 5 programs/universities

Create a free account to unlock full content!

By registering, you agree to our Privacy Statement and Terms and Conditions.

Details
Program Details
Degree
Masters
Major
Biomedical Sciences | Pharmacology | Genetics
Area of study
Health | Natural Science
Education type
On campus
Timing
Full time
Course Language
English
Tuition Fee
Average International Tuition Fee
SAR 200,000
About Program

Program Overview


Introduction to the Pharmacogenomics Program

The Pharmacogenomics track of the Master of Biomedical Sciences Program at Alfaisal University is designed to equip graduates with the knowledge and skills necessary to lead in the field of personalized healthcare in Saudi Arabia. This program is the first structured pharmacogenomics program in Saudi Arabia and is delivered in collaboration with King Faisal Specialist Hospital & Research Centre (KFSHRC).


Program Overview

The Pharmacogenomics track is a two-year program that blends academic excellence with clinical precision. The program provides access to real-world pharmacogenomics data and tools, as well as mentorship from leaders in pharmacogenomics and genomic medicine.


Career Prospects

Graduates of the Pharmacogenomics program are prepared for high-impact roles in the field, including:


  • Pharmacogenomics Consultants advising clinical care teams
  • Clinical Pharmacogenomics Specialists in hospitals and genomic centers
  • Laboratory Scientists in PGx-focused diagnostics
  • Pharmacogenomics researchers in pharma and academic innovation

What You Will Study

The curriculum includes:


Core Courses

  • Practicum A: Genome Sequencing
  • Fundamentals of Human Genetics and Genomics
  • Clinical Pharmacology
  • Translational Medicine
  • Biostatistics
  • Research Methodology
  • Biomedical Ethics
  • Introduction to Pharmacogenomics

Admission Requirements

To be eligible for the program, applicants must meet the following requirements:


  • Bachelor's Degree: Medicine, Pharmacy, Bachelor of Medical Laboratory Science (BMLS)
  • Minimum GPA: Good standing bachelor's degree (2/4 or 3/5)
  • English Proficiency: IELTS (Academic): 5.5, TOEFL: 65, STEP: 80
  • Letter of Recommendation: One letter of recommendation from academic or professional references
  • Application Fee: A non-refundable application fee of 600 SAR
  • Interview: There will be an interview with the program director

Tuition Fees

The total cost of the program is 200,000 SAR, which includes:


  • Application Fee (Non-Refundable): 600 SAR
  • Seat Reservation Fee (Non-Refundable): 5,000 SAR (included in the program's total tuition fee)

Scholarship

Alfaisal University provides thesis scholarships up to 50% for thesis programs only. To be eligible, students must:


  • Have a cumulative GPA of 3.00 out of 4.00 and above by the end of the first academic year
  • Make full payment of the total tuition fees (100,000 SAR) by the end of the first academic year

Program Highlights

  • Duration: Two years
  • Language: English
  • Credits: 43 Credit Hours

Who Should Apply

The Pharmacogenomics track of the Master of Biomedical Sciences program is ideal for:


  • Physicians
  • Clinical Pharmacists
  • Genetic Counselors
  • Laboratory Scientists

Research Areas

The program focuses on the application of pharmacogenomics in clinical practice, including:


  • Genetic testing and sequencing
  • Pharmacogenomics research and clinical application
  • Translational medicine and precision healthcare

Conclusion

The Pharmacogenomics track of the Master of Biomedical Sciences Program at Alfaisal University is a comprehensive program that provides students with the knowledge and skills necessary to lead in the field of personalized healthcare in Saudi Arabia. With its strong focus on clinical precision and research, this program is ideal for healthcare and science professionals looking to advance their careers in pharmacogenomics and precision medicine.


See More